Trimethadione
Overview of the anticonvulsant medication Trimethadione
Trimethadione | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Trimethadione is a medication used primarily in the treatment of epilepsy, specifically for the management of absence seizures. It belongs to the class of oxazolidinediones, which are known for their anticonvulsant properties.
Pharmacology
Trimethadione works by modulating the activity of voltage-gated calcium channels in the brain. This action helps to stabilize neuronal membranes and reduce the frequency of seizure activity. The drug is metabolized in the liver to its active metabolite, dimethadione, which is responsible for its therapeutic effects.
Medical uses
Trimethadione is primarily indicated for the treatment of absence seizures, also known as petit mal seizures. These seizures are characterized by brief, sudden lapses in attention and activity, often occurring in children. Trimethadione is typically used when other medications, such as ethosuximide or valproic acid, are not effective or cause unacceptable side effects.
Side effects
The use of trimethadione can lead to several side effects, some of which may be serious. Common side effects include:
Serious side effects may include:
- Blood dyscrasias such as agranulocytosis and aplastic anemia
- Hepatotoxicity
- Dermatological reactions such as rash and Stevens-Johnson syndrome
Contraindications
Trimethadione is contraindicated in patients with a history of hypersensitivity to the drug or any of its components. It should be used with caution in patients with liver disease or blood disorders.
History
Trimethadione was first introduced in the 1940s as one of the earliest anticonvulsant medications. It was widely used for the treatment of absence seizures before the development of newer agents with improved safety profiles.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD